Hzymes Biotech
Hzymes Biotech Vision: “Become a world-class provider of specialty enzyme products and services.”
Founded in 2015, Hzymes Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research and development, production, application, and technical services of core raw materials for biopharma and in vitro diagnostics. R & D and production centers have been set up in Shanghai, Wuhan, Suzhou, Qingdao, and Yichang.
Based on its technology platforms, hundreds of raw materials related to biopharma, vaccine production, and in vitro diagnosis have been developed. We also have a pharmaceutical GMP-level enzyme production system with a super-large production scale and super-high equipment standards. It has provided products and services to more than 100 domestic manufacturers of bio-pharmaceuticals, vaccine preparations, and in vitro diagnostic reagents. Meanwhile, our products have been exported to 30 overseas countries and regions. The company will continue to expand product fields, enrich product varieties, and make unremitting efforts to build Hzymes into a “world-class supplier of special enzyme products and services”!
In 2022, 6 raw materials of the Biopharmaceutical products obtained DMF FDA approval. (https://hzymesbiotech.com/2022/08/02/news-hzymes-biotech-completed-dmf-filing-for-6-kinds-of-pharmaceutical-raw-materials/)
- UltraNuclease (GMP Class)
- T7 RNA Polymerase
- RNase Inhibitors(recombinant):
- PyrophosphataseInorganic (yeast):
- Vaccinia Capping Enzyme
- mRNA Cap-2′-O-Methyltransferase
Featured Products
- Ultra Nuclease – GMP Standard, high thermal stability, DMF FDA approval in 2022, enzyme activity 1.00 x 10^6 U/mg
- RNase Assay Kit – High sensitivity ~0,313 pg/mL around 1,56×10^-9 U/μL
- DNase Assay Kit – High sensitivity ~1,25×10^-6 U/μL
- CHO HCP ELISA Kit – sensitivity ~0,7ng/mL. CV inter-batch is ≲10%, CV Inter-assay is ≳15%
- Recombinant Trypsin: – no-animal origin, GMP level, high stability after 20 times of freezing and thawing at 4 degrees or room temperature.
Product Categories
Services
mRNA
In the fight against the COVID-19, mRNA vaccine became famous and attracted lots of atten-tion. Based on its unique mechanism, mRNA drugs have great application potential in the fields of infectious disease prevention, cancer and the treatment of various diseases.
At present, the research hotspots of mRNA drugs mainly focus on the mode of action and the process route of mRNA. Although mRNA drug research has ushered in a booming market, it also faces imperfect challenges in raw materials, technology, regulations and supply chains.
Hzymes can provide enzyme raw materials, substrates and detection kits with high quality, as well as undertake commissioned development (CRO) services, to achieve compliant, quick, stable target in drug development and production.
POCT
The COVID-19 epidemic, began in 2020, has greatly promoted the development of the global molecular diagnostic market and technology. The market is rapidly expanding, competition is gradually intensifying, and new technologies are emerging one after another. Enterprises are facing urgent needs for technology upgrades and product application scenario expansion.
With the development of rapid amplification technology, freeze-drying process, integrated design of instruments and reagents, and constant temperature amplification technology, it is more convenient and faster to go out of the medical laboratory, and the value of user-centered molecular diagnosis POCT is becoming more and more obvious. The needs of users in different scenarios are different, but convenience, speed, sensitivity and accuracy, easy storage and transportation, and controllable costs are the continuous driving forces for market development.
The molecular diagnostic technology route that does not rely on medical laboratories has continuously made breakthroughs. In the near future, molecular diagnostic POCT is imperative. Hzyme is willing to work with industry colleagues to promote continuous technological breakthroughs. We sincerely invite you to participate in this molecular diagnostic POCT technology trend research activities.
LAMP
COVID-19 has put molecular diagnostic products around the world through an unprecedented test. In the event of human outbreaks and animal disease inspections, the demand for molecular diagnostic POCT products will continue to expand. The demand for simple, fast, accurate, and compatible molecular diagnostic POCT products has been highlighted under the normalized epidemic prevention mechanism. According to the situation of normalization of global epidemic prevention, Hzymes Biotech launched the overall solution of SFAC-LAMP molecular diagnostic raw materials and applications, providing simple, fast, accurate and compatible for application scenarios such as grass-roots medical institutions, airports, customs inspection and quarantine, animal epidemic prevention real-time detection, etc. technical solutions.
OEM
In vitro diagnostics and life sciences companies rely on continuous innovation and continuous optimization of products to meet scientific research and clinical trials. Business cooperation has effectively promoted the market to understand a variety of innovative products faster. In today’s increasingly uncertain world, access to safe and reliable raw materials and stable supply chains is especially important. Hzymes is committed to becoming a “world-class special enzyme products and service supplier”, engaged in enzyme raw material research for more than 20 years, providing high-performance products with a stable supply chain, customizing comprehensive solutions with a professional team, and promoting innovative projects with rich experience. Hzymes Biological Intelligent Manufacturing, help your outstanding achievements!
CRO / CDMO
Hzymes Biotech specialize in providing Recombinant Protein CRO / CDMO services to Clints in worldwide, which includes the design, optimization, and scale-up of protein expression systems, as well as the production, purification, and characterization of recombinant proteins. These services are crucial for the development of new therapeutics, diagnostics, and research tools, and have become a key component of the biotech industry.
Contact Us
The Krishgen support team strives to provide swift responses and resolution to your queries.